Hepatitis C elimination by 2030 in Malaysia: an achievable goal?
作者信息
Mohamed Rosmawati, Shabaruddin Fatiha H, Azzeri Amirah, McDonald Scott A, Dahlui Maznah
机构信息
Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmacy, University of Malaya, Kuala Lumpur, Malaysia.
出版信息
J Virus Erad. 2019 Nov 4;5(4):253. doi: 10.1016/S2055-6640(20)30029-7.
Abstract
摘要
相似文献
1
Hepatitis C elimination by 2030 in Malaysia: an achievable goal?马来西亚到2030年消除丙型肝炎：一个可实现的目标？
J Virus Erad. 2019 Nov 4;5(4):253. doi: 10.1016/S2055-6640(20)30029-7.
2
Chronic Viral Hepatitis in Malaysia: "Where are we now?".马来西亚的慢性病毒性肝炎：“我们目前的状况如何？”
Euroasian J Hepatogastroenterol. 2017 Jan-Jun;7(1):65-67. doi: 10.5005/jp-journals-10018-1214. Epub 2017 May 5.
3
Modelling the elimination of hepatitis C as a public health threat in Iceland: A goal attainable by 2020.模拟消除冰岛的丙型肝炎公共卫生威胁：2020 年可实现目标。
J Hepatol. 2018 May;68(5):932-939. doi: 10.1016/j.jhep.2017.12.013. Epub 2017 Dec 21.
4
A Stepwise Approach to a National Hepatitis C Screening Strategy in Malaysia to Meet the WHO 2030 Targets: Proposed Strategy, Coverage, and Costs.马来西亚实现世界卫生组织2030年目标的全国丙型肝炎筛查策略的逐步实施方法：拟议策略、覆盖范围和成本。
Value Health Reg Issues. 2019 May;18:112-120. doi: 10.1016/j.vhri.2018.12.005. Epub 2019 Mar 25.
5
Projections of the Healthcare Costs and Disease Burden due to Hepatitis C Infection under Different Treatment Policies in Malaysia, 2018-2040.2018-2040 年马来西亚不同治疗政策下丙型肝炎感染所致医疗费用和疾病负担预测。
Appl Health Econ Health Policy. 2018 Dec;16(6):847-857. doi: 10.1007/s40258-018-0425-3.
6
The role of the Primary Healthcare Network in Iran in hepatitis C virus elimination by 2030.伊朗初级卫生保健网络在2030年前消除丙型肝炎病毒方面的作用。
J Virus Erad. 2018 Jul 1;4(3):186-188. doi: 10.1016/S2055-6640(20)30265-X.
7
Elimination of Hepatitis Viruses: Bangladesh Scenario.消除肝炎病毒：孟加拉国的情况
Euroasian J Hepatogastroenterol. 2017 Jan-Jun;7(1):40-42. doi: 10.5005/jp-journals-10018-1209. Epub 2017 May 5.
8
The 2017 M Balasegaram Memorial Lecture: The Changing Landscape of Liver Diseases in Malaysia-60 Years On!2017年M·巴拉塞加拉姆纪念讲座：马来西亚60年来肝病领域的变化！
Malays J Med Sci. 2019 Mar;26(2):18-29. doi: 10.21315/mjms2019.26.2.3. Epub 2019 Apr 30.
9
Aetiology of acute hepatitis in Malaysia.
Southeast Asian J Trop Med Public Health. 1986 Jun;17(2):205-8.
10
Elimination of viral hepatitis by 2030: ambitious, but achievable.到2030年消除病毒性肝炎：目标宏伟，但切实可行。
Lancet Gastroenterol Hepatol. 2019 Feb;4(2):88-89. doi: 10.1016/S2468-1253(18)30420-5.
引用本文的文献
1
Utilizing Theory of Planned Behaviour to increase intention to participate in hepatitis C treatment therapy among Methadone maintenance therapy clients (MMT) in Malaysia: A cluster randomised control trial.利用计划行为理论提高马来西亚美沙酮维持治疗患者参与丙型肝炎治疗的意愿：一项整群随机对照试验。
PLoS One. 2025 May 22;20(5):e0324718. doi: 10.1371/journal.pone.0324718. eCollection 2025.
2
Budget impact analysis of two treatment approaches for hepatitis C in Malaysia through the use of voluntary and compulsory licensing options.马来西亚使用自愿和强制许可选择治疗丙型肝炎的两种方法的预算影响分析。
Front Public Health. 2023 Feb 22;11:1114560. doi: 10.3389/fpubh.2023.1114560. eCollection 2023.
3
Barriers to scaling up hepatitis C treatment in Malaysia: a qualitative study with key stakeholders.马来西亚扩大丙型肝炎治疗规模的障碍：与主要利益攸关方的定性研究。
BMC Public Health. 2022 Feb 21;22(1):371. doi: 10.1186/s12889-022-12786-w.
本文引用的文献
1
A Stepwise Approach to a National Hepatitis C Screening Strategy in Malaysia to Meet the WHO 2030 Targets: Proposed Strategy, Coverage, and Costs.马来西亚实现世界卫生组织2030年目标的全国丙型肝炎筛查策略的逐步实施方法：拟议策略、覆盖范围和成本。
Value Health Reg Issues. 2019 May;18:112-120. doi: 10.1016/j.vhri.2018.12.005. Epub 2019 Mar 25.
2
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission.加速消除病毒性肝炎：柳叶刀胃肠病学和肝脏病学委员会报告
Lancet Gastroenterol Hepatol. 2019 Feb;4(2):135-184. doi: 10.1016/S2468-1253(18)30270-X.
3
Projections of the Healthcare Costs and Disease Burden due to Hepatitis C Infection under Different Treatment Policies in Malaysia, 2018-2040.2018-2040 年马来西亚不同治疗政策下丙型肝炎感染所致医疗费用和疾病负担预测。
Appl Health Econ Health Policy. 2018 Dec;16(6):847-857. doi: 10.1007/s40258-018-0425-3.
Zotero 插件